United States Progressive Multifocal Leukoencephalopathy Drug Market Report 2017

December 2017 | 96 pages | ID: U9BD58D829FEN
QYResearch

Abstracts

In this report, the United States Progressive Multifocal Leukoencephalopathy Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Progressive Multifocal Leukoencephalopathy Drug in these regions, from 2012 to 2022 (forecast).

United States Progressive Multifocal Leukoencephalopathy Drug market competition by top manufacturers/players, with Progressive Multifocal Leukoencephalopathy Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Excision BioTherapeutics Inc
• Humabs BioMed SA
• Neurimmune Holding AG
• Neuway Pharma GmbH
• Pomona Ricerca SRL

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• EBT-103
• IKT-01427
• Imatinib Mesylate
• NI-307
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Research Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Progressive Multifocal Leukoencephalopathy Drug Market Report 2017

1 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG OVERVIEW

1.1 Product Overview and Scope of Progressive Multifocal Leukoencephalopathy Drug
1.2 Classification of Progressive Multifocal Leukoencephalopathy Drug by Product Category
  1.2.1 United States Progressive Multifocal Leukoencephalopathy Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Progressive Multifocal Leukoencephalopathy Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 EBT-103
  1.2.4 IKT-01427
  1.2.5 Imatinib Mesylate
  1.2.6 NI-307
  1.2.7 Others
1.3 United States Progressive Multifocal Leukoencephalopathy Drug Market by Application/End Users
  1.3.1 United States Progressive Multifocal Leukoencephalopathy Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Research Center
1.4 United States Progressive Multifocal Leukoencephalopathy Drug Market by Region
  1.4.1 United States Progressive Multifocal Leukoencephalopathy Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
  1.4.5 New England Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
  1.4.6 The South Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Progressive Multifocal Leukoencephalopathy Drug (2012-2022)
  1.5.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Progressive Multifocal Leukoencephalopathy Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Progressive Multifocal Leukoencephalopathy Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Progressive Multifocal Leukoencephalopathy Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Progressive Multifocal Leukoencephalopathy Drug Market Competitive Situation and Trends
  2.4.1 United States Progressive Multifocal Leukoencephalopathy Drug Market Concentration Rate
  2.4.2 United States Progressive Multifocal Leukoencephalopathy Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Progressive Multifocal Leukoencephalopathy Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales and Market Share by Region (2012-2017)
3.2 United States Progressive Multifocal Leukoencephalopathy Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Progressive Multifocal Leukoencephalopathy Drug Price by Region (2012-2017)

4 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Progressive Multifocal Leukoencephalopathy Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Progressive Multifocal Leukoencephalopathy Drug Price by Type (2012-2017)
4.4 United States Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales and Market Share by Application (2012-2017)
5.2 United States Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Excision BioTherapeutics Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Progressive Multifocal Leukoencephalopathy Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Humabs BioMed SA
  6.2.2 Progressive Multifocal Leukoencephalopathy Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Neurimmune Holding AG
  6.3.2 Progressive Multifocal Leukoencephalopathy Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Neuway Pharma GmbH
  6.4.2 Progressive Multifocal Leukoencephalopathy Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pomona Ricerca SRL
  6.5.2 Progressive Multifocal Leukoencephalopathy Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG MANUFACTURING COST ANALYSIS

7.1 Progressive Multifocal Leukoencephalopathy Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Progressive Multifocal Leukoencephalopathy Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Progressive Multifocal Leukoencephalopathy Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Progressive Multifocal Leukoencephalopathy Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Progressive Multifocal Leukoencephalopathy Drug
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure EBT-103 Product Picture
Figure IKT-01427 Product Picture
Figure Imatinib Mesylate Product Picture
Figure NI-307 Product Picture
Figure Others Product Picture
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Progressive Multifocal Leukoencephalopathy Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Players/Suppliers
Figure 2017 United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Players/Suppliers
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Players/Suppliers
Figure 2017 United States Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Players/Suppliers
Table United States Market Progressive Multifocal Leukoencephalopathy Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Progressive Multifocal Leukoencephalopathy Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Share of Top 3 Players/Suppliers
Figure United States Progressive Multifocal Leukoencephalopathy Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Progressive Multifocal Leukoencephalopathy Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Progressive Multifocal Leukoencephalopathy Drug Product Category
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs) by Region (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Region (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Region (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Region in 2016
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Region (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region in 2016
Table United States Progressive Multifocal Leukoencephalopathy Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs) by Type (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Type (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Share by Type (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type in 2016
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Progressive Multifocal Leukoencephalopathy Drug by Type (2012-2017)
Figure Revenue Market Share of Progressive Multifocal Leukoencephalopathy Drug by Type in 2016
Table United States Progressive Multifocal Leukoencephalopathy Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate by Type (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs) by Application (2012-2017)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application in 2016
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate by Application (2012-2017)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate by Application (2012-2017)
Table Excision BioTherapeutics Inc Basic Information List
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2012-2017)
Figure Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in United States (2012-2017)
Figure Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share in United States (2012-2017)
Table Humabs BioMed SA Basic Information List
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2012-2017)
Figure Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in United States (2012-2017)
Figure Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share in United States (2012-2017)
Table Neurimmune Holding AG Basic Information List
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2012-2017)
Figure Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in United States (2012-2017)
Figure Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share in United States (2012-2017)
Table Neuway Pharma GmbH Basic Information List
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2012-2017)
Figure Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in United States (2012-2017)
Figure Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share in United States (2012-2017)
Table Pomona Ricerca SRL Basic Information List
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2012-2017)
Figure Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in United States (2012-2017)
Figure Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Progressive Multifocal Leukoencephalopathy Drug
Figure Manufacturing Process Analysis of Progressive Multifocal Leukoencephalopathy Drug
Figure Progressive Multifocal Leukoencephalopathy Drug Industrial Chain Analysis
Table Raw Materials Sources of Progressive Multifocal Leukoencephalopathy Drug Major Players/Suppliers in 2016
Table Major Buyers of Progressive Multifocal Leukoencephalopathy Drug
Table Distributors/Traders List
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Progressive Multifocal Leukoencephalopathy Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources